In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a study ...

A decades-long study reveals that shedding extra weight in midlife, without medication or surgery, could reduce your risk of serious illness and help you live longer. Study: Weight Loss in Midlife, ...

GLP-1 drugs like Ozempic are reshaping obesity care, blending real weight loss gains with new questions about safety, access, ...

People who reduce excess weight in midlife can roughly halve their risk of developing chronic disease later in life. That’s the conclusion of three long-term studies from the UK and Finland, analyzed ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D).

More than 4,700 adults aged 55 to 75 were involved in the six-year study. A large six-year trial found that older adults who combined a Mediterranean diet with regular exercise were far less likely to ...

A major study from Tübingen found that prediabetic individuals who normalized their blood sugar through healthy habits — even without shedding pounds — cut their risk of type 2 diabetes by 71%.

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...